• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Announcements


RHY Rhythm recruits first patient in ColoSTAT clinical trialPRICE SENSITIVE18/03/19 download Created with Sketch. 117.77KB
RHY Appendix 4D and Half Yearly Report and AccountsPRICE SENSITIVE26/02/19 download Created with Sketch. 987.06KB
RHY RHY Signs first ColoSTAT site for Clinical Trial - Study 7PRICE SENSITIVE20/02/19 download Created with Sketch. 121.57KB
RHY Corporate PresentationPRICE SENSITIVE11/02/19 download Created with Sketch. 1.19MB
RHY Rhythm secures ethics approval for ColoSTAT clinical trial08/02/19 download Created with Sketch. 73.63KB
RHY Appendix 4CPRICE SENSITIVE29/01/19 download Created with Sketch. 298.71KB
RHY RHY Welcomes Australian Government's $10m Investment23/01/19 download Created with Sketch. 96.71KB
RHY Rhythm Receives R&D Tax Incentive Refund11/12/18 download Created with Sketch. 77.04KB
RHY Rhythm Completes Reagent Development ProgramPRICE SENSITIVE05/12/18 download Created with Sketch. 87.19KB
RHY Appointment of CEO - Senior Management ChangesPRICE SENSITIVE28/11/18 download Created with Sketch. 611.82KB
RHY Results of Meeting26/11/18 download Created with Sketch. 166.56KB
RHY AGM PresentationPRICE SENSITIVE26/11/18 download Created with Sketch. 822.23KB
RHY Change of Director's Interest Notice14/11/18 download Created with Sketch. 245.81KB
RHY Appendix 4CPRICE SENSITIVE29/10/18 download Created with Sketch. 220.99KB
RHY Notice of Annual General Meeting/Proxy Form12/10/18 download Created with Sketch. 409.79KB
RHY Final Antibody Selection CompletePRICE SENSITIVE03/10/18 download Created with Sketch. 85.87KB
RHY Appendix 4G and Corporate Governance Statement31/08/18 download Created with Sketch. 200.3KB
RHY Annual Report31/08/18 download Created with Sketch. 1.59MB
RHY Appendix 4EPRICE SENSITIVE31/08/18 download Created with Sketch. 30.55KB
RHY Appendix 3B - release from escrow29/08/18 download Created with Sketch. 469.64KB
RHY Change in substantial holding13/08/18 download Created with Sketch. 187.14KB
RHY Release of Restricted Securities from Escrow06/08/18 download Created with Sketch. 104.26KB
RHY Appendix 4CPRICE SENSITIVE30/07/18 download Created with Sketch. 199.08KB
RHY Rhythm completes cloning of key reagent ahead of schedulePRICE SENSITIVE21/06/18 download Created with Sketch. 74.01KB
RHY Merchant Group increases stake in Rhythm from 5% to 7%15/06/18 download Created with Sketch. 211.02KB
RHY RHY Welcomes Leading Biotech Fund as New Major Shareholder12/06/18 download Created with Sketch. 171.5KB
RHY Appendix 3B22/05/18 download Created with Sketch. 239.25KB
RHY Key Management Appointments at Rhythm Biosciences22/05/18 download Created with Sketch. 74.76KB
RHY Rhythm Granted Biomarker Patent in EuropePRICE SENSITIVE16/05/18 download Created with Sketch. 110.56KB
RHY RHY's Four Antibodies Pass all Three Key Screening TestsPRICE SENSITIVE14/05/18 download Created with Sketch. 131.33KB
RHY Appendix 4CPRICE SENSITIVE30/04/18 download Created with Sketch. 219.51KB
RHY Reagent Development UpdatePRICE SENSITIVE24/04/18 download Created with Sketch. 129.83KB
RHY Change of Director's Interest Notice23/03/18 download Created with Sketch. 174.9KB
RHY Appendix 4D - Half Yearly ReportPRICE SENSITIVE01/03/18 download Created with Sketch. 41.74KB
RHY Half Yearly Report and Accounts27/02/18 download Created with Sketch. 951.04KB
RHY Consultation with Major Diagnostic Labs Underway - Update15/02/18 download Created with Sketch. 157.59KB
RHY Rhythm reports reagent development updatePRICE SENSITIVE07/02/18 download Created with Sketch. 203.98KB
RHY Quarterly report and Appendix 4CPRICE SENSITIVE31/01/18 download Created with Sketch. 936.04KB
RHY CSIRO and Rhythm Commence Development of Key ReagentsPRICE SENSITIVE24/01/18 download Created with Sketch. 90.64KB
RHY CSIRO to assist Rhythm Biosciences develop key reagentsPRICE SENSITIVE09/01/18 download Created with Sketch. 558.15KB
RHY Becoming a substantial holder07/12/17 download Created with Sketch. 67.14KB
RHY Becoming a substantial holder07/12/17 download Created with Sketch. 1.32MB
RHY Appendix 3X - Lockett06/12/17 download Created with Sketch. 726.18KB
RHY Appendix 3X - Tanner06/12/17 download Created with Sketch. 721.6KB
RHY Appendix 3X - Panaccio06/12/17 download Created with Sketch. 717.51KB
RHY Appendix 3X - White06/12/17 download Created with Sketch. 714.99KB
RHY Corporate Governance Statement06/12/17 download Created with Sketch. 313.97KB
RHY Audited Special Purpose Report 1/6/17 to 30/6/1706/12/17 download Created with Sketch. 654.46KB
RHY Audited Special Purpose Report 1/7/17 to 31/8/1706/12/17 download Created with Sketch. 465.19KB
RHY Securities Trading Policy06/12/17 download Created with Sketch. 910.55KB
RHY Performance Rights Plan06/12/17 download Created with Sketch. 452.79KB
RHY Employee Security Ownership Plan06/12/17 download Created with Sketch. 531.71KB
RHY Constitution06/12/17 download Created with Sketch. 174.9KB
RHY Top 20 Shareholders06/12/17 download Created with Sketch. 31.99KB
RHY Distribution Schedule06/12/17 download Created with Sketch. 30.35KB
RHY Pre-quotation Disclosure06/12/17 download Created with Sketch. 305.77KB
RHY Appendix 1A and Information Form and Checklist06/12/17 download Created with Sketch. 1013.79KB
RHY Replacement Prospectus06/12/17 download Created with Sketch. 11.56MB
RHY Admission to Official ListPRICE SENSITIVE06/12/17 download Created with Sketch. 216.35KB
RHY ASX Notice - Admission and Quotation06/12/17 download Created with Sketch. 254.74KB
RHY Rhythm recruits first patient in ColoSTAT clinical trial
18/03/19PRICE SENSITIVE download Created with Sketch. 117.77KB
RHY Appendix 4D and Half Yearly Report and Accounts
26/02/19PRICE SENSITIVE download Created with Sketch. 987.06KB
RHY RHY Signs first ColoSTAT site for Clinical Trial - Study 7
20/02/19PRICE SENSITIVE download Created with Sketch. 121.57KB
RHY Corporate Presentation
11/02/19PRICE SENSITIVE download Created with Sketch. 1.19MB
RHY Rhythm secures ethics approval for ColoSTAT clinical trial
08/02/19 download Created with Sketch. 73.63KB
RHY Appendix 4C
29/01/19PRICE SENSITIVE download Created with Sketch. 298.71KB
RHY RHY Welcomes Australian Government's $10m Investment
23/01/19 download Created with Sketch. 96.71KB
RHY Rhythm Receives R&D Tax Incentive Refund
11/12/18 download Created with Sketch. 77.04KB
RHY Rhythm Completes Reagent Development Program
05/12/18PRICE SENSITIVE download Created with Sketch. 87.19KB
RHY Appointment of CEO - Senior Management Changes
28/11/18PRICE SENSITIVE download Created with Sketch. 611.82KB
RHY Results of Meeting
26/11/18 download Created with Sketch. 166.56KB
RHY AGM Presentation
26/11/18PRICE SENSITIVE download Created with Sketch. 822.23KB
RHY Change of Director's Interest Notice
14/11/18 download Created with Sketch. 245.81KB
RHY Appendix 4C
29/10/18PRICE SENSITIVE download Created with Sketch. 220.99KB
RHY Notice of Annual General Meeting/Proxy Form
12/10/18 download Created with Sketch. 409.79KB
RHY Final Antibody Selection Complete
03/10/18PRICE SENSITIVE download Created with Sketch. 85.87KB
RHY Appendix 4G and Corporate Governance Statement
31/08/18 download Created with Sketch. 200.3KB
RHY Annual Report
31/08/18 download Created with Sketch. 1.59MB
RHY Appendix 4E
31/08/18PRICE SENSITIVE download Created with Sketch. 30.55KB
RHY Appendix 3B - release from escrow
29/08/18 download Created with Sketch. 469.64KB
RHY Change in substantial holding
13/08/18 download Created with Sketch. 187.14KB
RHY Release of Restricted Securities from Escrow
06/08/18 download Created with Sketch. 104.26KB
RHY Appendix 4C
30/07/18PRICE SENSITIVE download Created with Sketch. 199.08KB
RHY Rhythm completes cloning of key reagent ahead of schedule
21/06/18PRICE SENSITIVE download Created with Sketch. 74.01KB
RHY Merchant Group increases stake in Rhythm from 5% to 7%
15/06/18 download Created with Sketch. 211.02KB
RHY RHY Welcomes Leading Biotech Fund as New Major Shareholder
12/06/18 download Created with Sketch. 171.5KB
RHY Appendix 3B
22/05/18 download Created with Sketch. 239.25KB
RHY Key Management Appointments at Rhythm Biosciences
22/05/18 download Created with Sketch. 74.76KB
RHY Rhythm Granted Biomarker Patent in Europe
16/05/18PRICE SENSITIVE download Created with Sketch. 110.56KB
RHY RHY's Four Antibodies Pass all Three Key Screening Tests
14/05/18PRICE SENSITIVE download Created with Sketch. 131.33KB
RHY Appendix 4C
30/04/18PRICE SENSITIVE download Created with Sketch. 219.51KB
RHY Reagent Development Update
24/04/18PRICE SENSITIVE download Created with Sketch. 129.83KB
RHY Change of Director's Interest Notice
23/03/18 download Created with Sketch. 174.9KB
RHY Appendix 4D - Half Yearly Report
01/03/18PRICE SENSITIVE download Created with Sketch. 41.74KB
RHY Half Yearly Report and Accounts
27/02/18 download Created with Sketch. 951.04KB
RHY Consultation with Major Diagnostic Labs Underway - Update
15/02/18 download Created with Sketch. 157.59KB
RHY Rhythm reports reagent development update
07/02/18PRICE SENSITIVE download Created with Sketch. 203.98KB
RHY Quarterly report and Appendix 4C
31/01/18PRICE SENSITIVE download Created with Sketch. 936.04KB
RHY CSIRO and Rhythm Commence Development of Key Reagents
24/01/18PRICE SENSITIVE download Created with Sketch. 90.64KB
RHY CSIRO to assist Rhythm Biosciences develop key reagents
09/01/18PRICE SENSITIVE download Created with Sketch. 558.15KB
RHY Becoming a substantial holder
07/12/17 download Created with Sketch. 67.14KB
RHY Becoming a substantial holder
07/12/17 download Created with Sketch. 1.32MB
RHY Appendix 3X - Lockett
06/12/17 download Created with Sketch. 726.18KB
RHY Appendix 3X - Tanner
06/12/17 download Created with Sketch. 721.6KB
RHY Appendix 3X - Panaccio
06/12/17 download Created with Sketch. 717.51KB
RHY Appendix 3X - White
06/12/17 download Created with Sketch. 714.99KB
RHY Corporate Governance Statement
06/12/17 download Created with Sketch. 313.97KB
RHY Audited Special Purpose Report 1/6/17 to 30/6/17
06/12/17 download Created with Sketch. 654.46KB
RHY Audited Special Purpose Report 1/7/17 to 31/8/17
06/12/17 download Created with Sketch. 465.19KB
RHY Securities Trading Policy
06/12/17 download Created with Sketch. 910.55KB
RHY Performance Rights Plan
06/12/17 download Created with Sketch. 452.79KB
RHY Employee Security Ownership Plan
06/12/17 download Created with Sketch. 531.71KB
RHY Constitution
06/12/17 download Created with Sketch. 174.9KB
RHY Top 20 Shareholders
06/12/17 download Created with Sketch. 31.99KB
RHY Distribution Schedule
06/12/17 download Created with Sketch. 30.35KB
RHY Pre-quotation Disclosure
06/12/17 download Created with Sketch. 305.77KB
RHY Appendix 1A and Information Form and Checklist
06/12/17 download Created with Sketch. 1013.79KB
RHY Replacement Prospectus
06/12/17 download Created with Sketch. 11.56MB
RHY Admission to Official List
06/12/17PRICE SENSITIVE download Created with Sketch. 216.35KB
RHY ASX Notice - Admission and Quotation
06/12/17 download Created with Sketch. 254.74KB
(20min delay)
Last
16.0¢
Change
0.000(0.00%)
Mkt cap ! $16.12M
Open High Low Value Volume
16.0¢ 16.0¢ 16.0¢ $1.003K 6.269K

Buyers (Bids)

No. Vol. Price($)
1 3600 15.5¢
 

Sellers (Offers)

Price($) Vol. No.
16.0¢ 47064 3
View Market Depth
Last update - 10.06am 19/04/2019 (20 minute delay) ?
RHY (ASX) Chart
GET SUPPORT arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.